Kimia Bioscien.

23
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE285U01025
  • NSEID:
  • BSEID: 530313
INR
29.00
-0.55 (-1.86%)
BSENSE

Dec 05

BSE+NSE Vol: 1.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.39% vs -18.39% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 4,289.04% vs 90.29% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -9.76% vs 18.96% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 281.07% vs 43.24% in Mar 2024

Compare Profit and Loss Results of Kimia Bioscien.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
118.00
43.00
75.00
174.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
118.00
43.00
75.00
174.42%
Expenditure (Ex Depriciation)
Stock Adjustments
-3.00
3.00
-6.00
-200.00%
Raw Materials Consumed
74.00
2.00
72.00
3,600.00%
Power & Fuel Cost
5.00
18.00
-13.00
-72.22%
Employee Cost
13.00
16.00
-3.00
-18.75%
Operating Expenses
1.00
12.00
-11.00
-91.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
0.00
2.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
98.00
58.00
40.00
68.97%
Operating Profit (PBDIT) excl Other Income
20.00
-15.00
35.00
233.33%
Other Income
1.00
0.00
1.00
0%
Operating Profit (PBDIT)
21.00
-14.00
35.00
250.00%
Interest
4.00
5.00
-1.00
-20.00%
Profit before Depriciation and Tax
17.00
-20.00
37.00
185.00%
Depreciation
3.00
6.00
-3.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
-26.00
39.00
150.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
-26.00
39.00
150.00%
Provision for Tax
4.00
0.00
4.00
0%
Profit After Tax
9.00
-26.00
35.00
134.62%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-10.00
-270.00
260.00
96.30%
Profit Available for appropriations
0.00
-297.00
297.00
100.00%
Appropriations
0.00
-297.00
297.00
100.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.03
-12.49
14.52
116.25%
Profit And Loss - Net Sales
Net Sales 118.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.39% vs -18.39% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.25 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4,289.04% vs 90.29% in Mar 2024

Profit And Loss - Interest
Interest 4.56 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -9.76% vs 18.96% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 9.61 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 281.07% vs 43.24% in Mar 2024